Sources | Names Used |
---|---|
CTRPv2 | BRD-K55116708 |
PharmacoGx | BRD-K55116708 |
Database | Identifier |
---|---|
Smiles: | C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)Nc3ccccc3N)Oc4c(NC(=O)Nc5ccccc5)cccc4C1=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF130 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | NCBP3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ZAR1L | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | NMS | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | CLEC12A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | CD3D | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | OR10T2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | ANP32D | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | ARSD | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | MUM1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |